TRIM6-TRIM34
Basic information
Region (hg38): 11:5596725-5644398
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (13 variants)
- not provided (3 variants)
- Malignant tumor of prostate (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRIM6-TRIM34 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 3 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 12 | 13 | ||||
Total | 0 | 0 | 14 | 3 | 0 |
Variants in TRIM6-TRIM34
This is a list of pathogenic ClinVar variants found in the TRIM6-TRIM34 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-5603734-A-G | not specified | Uncertain significance (Jan 26, 2022) | ||
11-5604536-G-T | Likely benign (Jun 18, 2018) | |||
11-5604572-G-A | Likely benign (Jun 18, 2018) | |||
11-5610798-A-G | not specified | Uncertain significance (Sep 27, 2021) | ||
11-5610801-C-T | not specified | Uncertain significance (Jan 03, 2024) | ||
11-5610816-T-C | not specified | Uncertain significance (Dec 16, 2022) | ||
11-5610875-T-C | not specified | Uncertain significance (Sep 26, 2022) | ||
11-5610891-A-G | Likely benign (Mar 01, 2023) | |||
11-5610949-G-C | not specified | Uncertain significance (May 23, 2023) | ||
11-5610976-G-C | not specified | Uncertain significance (May 11, 2022) | ||
11-5611062-A-G | not specified | Uncertain significance (Aug 28, 2023) | ||
11-5611077-A-G | not specified | Uncertain significance (May 23, 2024) | ||
11-5611163-C-T | not specified | Uncertain significance (Mar 12, 2024) | ||
11-5611167-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
11-5611182-T-C | not specified | Uncertain significance (Apr 04, 2023) | ||
11-5611218-A-C | not specified | Uncertain significance (Oct 04, 2022) | ||
11-5611295-C-A | not specified | Uncertain significance (Aug 12, 2021) | ||
11-5611314-C-G | not specified | Uncertain significance (Feb 17, 2024) | ||
11-5611325-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
11-5611329-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
11-5632327-G-A | Malignant tumor of prostate | Uncertain significance (-) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRIM6-TRIM34 | protein_coding | protein_coding | ENST00000354852 | 14 | 47674 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.31e-19 | 0.135 | 125511 | 0 | 237 | 125748 | 0.000943 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.609 | 481 | 445 | 1.08 | 0.0000229 | 5517 |
Missense in Polyphen | 126 | 128.12 | 0.98345 | 1708 | ||
Synonymous | 0.739 | 152 | 164 | 0.927 | 0.00000802 | 1594 |
Loss of Function | 1.37 | 34 | 43.8 | 0.777 | 0.00000256 | 479 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00318 | 0.00306 |
Ashkenazi Jewish | 0.000596 | 0.000595 |
East Asian | 0.000874 | 0.000870 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.00113 | 0.000818 |
Middle Eastern | 0.000874 | 0.000870 |
South Asian | 0.000525 | 0.000490 |
Other | 0.00114 | 0.00114 |
dbNSFP
Source:
- Pathway
- Cytokine Signaling in Immune system;Immune System;Interferon gamma signaling;Interferon Signaling
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.52
- rvis_percentile_EVS
- 80.36
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.132
- ghis
- 0.394
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.268
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- Cellular component
- Molecular function
- zinc ion binding